Get the Daily Brief
Latest Biotech News
Epigenetics and Molecular Biomarkers in Cancer and Disease
Researchers have identified key molecular markers and mechanisms driving cancer and other diseases. A landmark study detailed the epigenetic diversity in advanced prostate cancer, revealing...
Regulatory and Industry Dynamics Amid HHS Reorganization and Biotech Funding
The U.S. Department of Health and Human Services (HHS) faces legal injunctions halting planned workforce reductions, stemming from lawsuits alleging unauthorized agency restructuring....
Psychedelic Therapies Advance with Positive Clinical Data and Strategic Mergers
Clinical advancements in psychedelic-based treatments are accelerating notably. Beckley Psytech’s intranasal mebufotenin demonstrated significant symptom reductions in treatment-resistant...
Breakthroughs in Oncology: Bispecific Antibodies and Tumor Immunology
Regeneron Pharmaceuticals achieved FDA accelerated approval for Lynozyfic (linvoseltamab), a bispecific antibody targeting BCMA and CD3 in multiple myeloma, marking a significant milestone in...
AI Integration and Innovation in Biomanufacturing and Diagnostic Tools
The incorporation of artificial intelligence (AI) across biomanufacturing and diagnostics is gaining strategic momentum. While regulators like the FDA and EMA explore adaptive frameworks to...
Genomic and Molecular Technology Development for Precision Medicine
Cutting-edge tools in genomics and molecular biology continue to enable transformative advances in medicine. Novel methods for accurate CRISPR off-target prediction have improved with...
FDA Halts HHS Layoffs: Court Challenges Agency Restructuring
Two federal courts have issued preliminary injunctions blocking parts of the U.S. Department of Health and Human Services’ (HHS) broad reorganization plans and workforce reductions, siding with...
Regeneron Gains US Approval for Multiple Myeloma Bispecific Antibody
Regeneron has secured accelerated FDA approval for linvoseltamab, its bispecific antibody targeting multiple myeloma in adults with relapsed or refractory disease. This milestone follows delays...
Advances in AI-Driven Diagnostic and Drug Discovery Platforms
Several biotech firms and academic centers are leveraging artificial intelligence to accelerate diagnostics and therapeutic development. Adaptive Biotechnologies has integrated its ClonoSeq MRD...
Biotech Venture Funds Capitalize on Market Opportunities
Venture capital firms continue to capitalize on attractive valuations in biotechnology. Catalio Capital Management closed its fourth fund at over $400 million, deploying capital into innovative...
Psychedelic Therapies Show Promise in Treatment-Resistant Depression
Beckley Psytech and Atai Life Sciences announced positive Phase 2b data for intranasal mebufotenin (BPL-003), demonstrating significant symptom reductions in treatment-resistant depression versus...
Chemotherapy’s Genetic Impact Provides Insight for Safer Cancer Treatments
A comprehensive genomic study has identified distinct mutational signatures in normal blood cells correlated with exposure to 21 different chemotherapy drugs. Led by the Wellcome Sanger Institute...
Emerging Therapies Targeting Pain and Obesity Take Flight
Following Vertex Pharmaceuticals’ landmark approval of a selective sodium channel blocker addressing acute pain, SiteOne Therapeutics has garnered significant investment and agreed to a potential...
Novel Cancer Immunotherapies and Biomarkers Surface in Clinical Research
Recent studies uncover various innovations improving cancer therapy and diagnosis. Biokin achieved a Phase 3 success with a bispecific antibody-drug conjugate licensed to Bristol Myers Squibb. New...
AI and Automation Innovate Neuroscience and Neurodegenerative Disease Research
Cutting-edge interdisciplinary efforts are leveraging AI to elucidate and treat neurological disorders. Digital speech biomarker studies quantify levodopa response variability in Parkinson’s...
AbbVie’s $2.1 Billion Bet on In Vivo CAR-T Therapy
AbbVie announced the acquisition of Capstan Therapeutics for up to $2.1 billion, aiming to deepen its exploration of in vivo CAR-T therapies—a promising approach that engineers immune cells...
AI Advances in Cancer Detection and Diagnostics
Recent breakthroughs illustrate AI’s expanding role in oncology, with institutions developing models for early cancer detection and enhanced diagnostic accuracy. The University of Sharjah unveiled...
Psychedelic Therapies Gain Mid-Stage Clinical Momentum
Beckley Psytech and Atai Life Sciences reported positive Phase 2b results for the psychedelic compound BPL-003 (intranasal mebufotenin) in treatment-resistant depression, exceeding efficacy...
Genetic Damage from Chemotherapy Illuminates Safer Treatment Paths
Groundbreaking studies from the Wellcome Sanger Institute and collaborators have characterized distinct mutational signatures induced by diverse chemotherapy drugs on healthy blood cells,...
New Agents and Strategies in Obesity and Metabolic Disease
Innovative approaches to obesity treatment are emerging, including Syntis Bio’s novel intestinal coating technology mimicking gastric bypass effects, funded with $38 million to advance clinical...